Published in J Infect Dis on July 01, 1994
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax (2001) 3.38
Viruses and bacteria in the etiology of the common cold. J Clin Microbiol (1998) 3.24
Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response. Microbiol Rev (1996) 2.20
Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. Thorax (1996) 1.78
Bacterial coinfections in children with viral wheezing. Eur J Clin Microbiol Infect Dis (2006) 0.94
Human immune response against outer membrane proteins of Moraxella (Branhamella) catarrhalis determined by immunoblotting and enzyme immunoassay. Clin Diagn Lab Immunol (1995) 0.92
Galactose residues on the lipooligosaccharide of Moraxella catarrhalis 26404 form the epitope recognized by the bactericidal antiserum from conjugate vaccination. Infect Immun (2008) 0.80
Bactericidal monoclonal antibody against Moraxella catarrhalis lipooligosaccharide cross-reacts with Haemophilus Spp. Curr Microbiol (2007) 0.79
Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet (1988) 7.59
Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study. Ann Intern Med (1992) 5.65
Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet (1983) 5.63
Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J (2000) 4.87
A toxoid vaccine for pertussis as well as diphtheria? Lessons to be relearned. Lancet (1996) 4.30
Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax (2001) 3.72
Study of community acquired pneumonia aetiology (SCAPA) in adults admitted to hospital: implications for management guidelines. Thorax (2001) 3.38
Viruses and bacteria in the etiology of the common cold. J Clin Microbiol (1998) 3.24
Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report. N Engl J Med (1987) 2.83
Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. J Infect Dis (1991) 2.83
Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease. Circulation (1993) 2.70
Diagnosis of bacteremic pneumococcal pneumonia by amplification of pneumolysin gene fragment in serum. J Infect Dis (1995) 2.62
Protective efficacy of monoclonal antibodies to class 1 and class 3 outer membrane proteins of Neisseria meningitidis B:15:P1.16 in infant rat infection model: new prospects for vaccine development. Microb Pathog (1987) 2.40
Invasive pneumococcal infections: incidence, predisposing factors, and prognosis. Rev Infect Dis (1985) 2.26
The genus-specific antigen of Chlamydia: resemblance to the lipopolysaccharide of enteric bacteria. Science (1983) 2.22
Comparative evaluation of potential components for group B meningococcal vaccine by passive protection in the infant rat and in vitro bactericidal assay. Vaccine (1989) 2.20
Aetiology of community-acquired pneumonia in children treated in hospital. Eur J Pediatr (1993) 2.10
Cross-reactivity between Chlamydiazyme and Acinetobacter strains. N Engl J Med (1986) 2.09
Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg (2001) 2.08
Comparison of broad-range bacterial PCR and culture of cerebrospinal fluid for diagnosis of community-acquired bacterial meningitis. Clin Microbiol Infect (2007) 2.05
Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J Infect Dis (2000) 2.04
Measurement of antibody responses to pneumolysin--a promising method for the presumptive aetiological diagnosis of pneumococcal pneumonia. J Infect (1989) 2.00
Use of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in Pakistan for surveillance for antimicrobial resistance. Pediatr Infect Dis J (1993) 1.95
Epidemiology of invasive pneumococcal infections in children in Finland. JAMA (1992) 1.90
Association of Helicobacter pylori infection with elevated serum lipids. Atherosclerosis (1999) 1.90
Infectious etiologies in acute exacerbation of COPD. Diagn Microbiol Infect Dis (2001) 1.80
Infections, inflammation, and the risk of coronary heart disease. Circulation (2000) 1.77
Pneumolysin PCR-based diagnosis of invasive pneumococcal infection in children. J Clin Microbiol (1999) 1.75
Comparison of four different sampling methods for detecting pharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children. J Clin Microbiol (1997) 1.74
Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm. Arterioscler Thromb Vasc Biol (1997) 1.74
Comparison of PCR assay with bacterial culture for detecting Streptococcus pneumoniae in middle ear fluid of children with acute otitis media. J Clin Microbiol (1994) 1.71
Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J (1990) 1.69
Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections. J Clin Microbiol (1998) 1.68
Etiology of acute lower respiratory tract infections in Gambian children: I. Acute lower respiratory tract infections in infants presenting at the hospital. Pediatr Infect Dis J (1991) 1.66
The bacteriology of acute otitis media in children with special reference to Streptococcus pneumoniae as studied by bacteriological and antigen detection methods. Scand J Infect Dis (1981) 1.59
Etiology of childhood pneumonia: serologic results of a prospective, population-based study. Pediatr Infect Dis J (1998) 1.59
Class-specific antibody response to group B Neisseria meningitidis capsular polysaccharide: use of polylysine precoating in an enzyme-linked immunosorbent assay. Infect Immun (1982) 1.58
Etiology of acute lower respiratory tract infections in Gambian children: II. Acute lower respiratory tract infection in children ages one to nine years presenting at the hospital. Pediatr Infect Dis J (1991) 1.57
Subtyping of common pediatric pneumococcal serotypes from invasive disease and pharyngeal carriage in Finland. J Infect Dis (1996) 1.54
History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin. J Pediatr (1990) 1.53
Occurrence of type-1C fimbriae on Escherichia coli strains isolated from human extraintestinal infections. J Gen Microbiol (1985) 1.53
Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr Infect Dis J (2000) 1.50
Clinical efficacy of pneumococcal vaccine in the elderly: a randomized, single-blind population-based trial. Am J Med (1997) 1.50
Parapertussis infection followed by pertussis infection. Lancet (1994) 1.49
Variability of penicillin-binding proteins from penicillin-sensitive Streptococcus pneumoniae. J Infect Dis (1991) 1.48
Etiology of community-acquired pneumonia in children based on antibody responses to bacterial and viral antigens. Pediatr Infect Dis J (1989) 1.48
The latex agglutination test for the diagnosis of meningococcal and haemophilus influenzae meningitis. Scand J Infect Dis (1977) 1.47
Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis (2001) 1.47
Protective levels of serum antibodies stimulated in infants by two injections of Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugate. J Pediatr (1989) 1.46
Comparison of ELISA and RIA for measurement of pneumococcal antibodies before and after vaccination with 14-valent pneumococcal capsular polysaccharide vaccine. J Clin Pathol (1981) 1.44
Evaluation of gene-technological and conventional methods in the identification of Streptococcus pneumoniae. J Microbiol Methods (2002) 1.42
Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. Microb Pathog (1996) 1.41
Immunologically related ketodeoxyoctonate-containing structures in Chlamydia trachomatis, Re mutants of Salmonella species, and Acinetobacter calcoaceticus var. anitratus. Infect Immun (1984) 1.41
The etiology of community-acquired pneumonia among hospitalized patients during a Chlamydia pneumoniae epidemic in Finland. J Infect Dis (1995) 1.40
Etiology and treatment of community-acquired pneumonia in ambulatory children. Pediatr Infect Dis J (1999) 1.40
Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol (1985) 1.39
Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland. Eur J Clin Microbiol Infect Dis (1993) 1.38
Evaluation of sampling sites for detection of upper respiratory tract carriage of Streptococcus pneumoniae and Haemophilus influenzae among healthy Filipino infants. J Clin Microbiol (1995) 1.38
Antigenic variation of penicillin-binding proteins from penicillin-resistant clinical strains of Streptococcus pneumoniae. J Infect Dis (1991) 1.36
Pneumococcal vaccine and otitis media. Lancet (1980) 1.31
Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits. Infect Immun (1997) 1.27
White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children. Eur Respir J (1997) 1.27
Preliminary serologic evidence for a pathogenic role of Branhamella catarrhalis. J Infect Dis (1981) 1.27
Diagnosis of pneumonia by cultures, bacterial and viral antigen detection tests, and serology with special reference to antibodies against pneumococcal antigens. J Infect Dis (1991) 1.27
Effect of cefoperazone on faecal flora. J Antimicrob Chemother (1983) 1.26
Clinical, metabolic, and antibody responses of adult volunteers to an investigational vaccine composed of pertussis toxin inactivated by hydrogen peroxide. J Pediatr (1988) 1.25
Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae. Microb Pathog (1996) 1.25
The aetiology of pneumonia. Application of bacterial serology and basic laboratory methods. J Infect (1987) 1.24
Role of type 1 and S fimbriae in the pathogenesis of Escherichia coli O18:K1 bacteremia and meningitis in the infant rat. Infect Immun (1988) 1.23
Ceftazidime: pharmacokinetics in patients and effects on the renal function. J Antimicrob Chemother (1982) 1.22
Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis (1986) 1.22
Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer (1997) 1.21
Serotypes and clinical manifestations of invasive group B streptococcal infections in western Sweden 1998-2001. Clin Microbiol Infect (2004) 1.20
Bacterial coinfection in children hospitalized with respiratory syncytial virus infections. Pediatr Infect Dis J (1989) 1.20
Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease. Epidemiol Infect (1997) 1.20
Incidence, predisposing factors and manifestations of invasive Haemophilus influenzae infections in adults. Eur J Clin Microbiol (1984) 1.20
Acute lower-respiratory-tract infection associated with chlamydial TWAR antibody in Filipino children. J Infect Dis (1988) 1.20
The causes of hospital-treated acute lower respiratory tract infection in children. Am J Dis Child (1991) 1.20
Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. Clin Infect Dis (1998) 1.19
Comparison of counter-current immunoelectrophoresis, latex agglutination, and radioimmunoassay in detection of soluble capsular polysaccharide antigens of Haemophilus influenzae type b and Neisseria meningitidis of groups A or C. J Clin Pathol (1978) 1.19
Sinusitis in the common cold. J Allergy Clin Immunol (1998) 1.18
First and second dose antibody responses to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis (1986) 1.18
Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases. Rev Infect Dis (1990) 1.16
Etiology of community-acquired pneumonia in out-patients. Eur J Clin Microbiol (1986) 1.16
Serologically indicated pneumococcal respiratory infection in children. Scand J Infect Dis (1992) 1.15
Clinical and immunologic responses to the capsular polysaccharide of Haemophilus influenzae type b alone or conjugated to tetanus toxoid in 18- to 23-month-old children. J Pediatr (1988) 1.14
Pneumonia in childhood: etiology and response to antimicrobial therapy. Eur J Clin Microbiol Infect Dis (1992) 1.14
Pneumococcal carriage in children during their first two years: important role of family exposure. Pediatr Infect Dis J (2001) 1.13
A multi-laboratory evaluation of an enzyme-linked immunoassay quantitating human antibodies to Streptococcus pneumoniae polysaccharides. Immunol Invest (2001) 1.13
New standardised texts for assessing reading performance in four European languages. Br J Ophthalmol (2006) 1.11
Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms. J Vasc Surg (1997) 1.11
Serological grouping of meningococci and encapsulated Haemophilus influenzae strains by latex agglutination. J Clin Microbiol (1979) 1.11
Etiology of respiratory tract infection in adults in a general practice setting. Eur J Clin Microbiol Infect Dis (1998) 1.11
New method to assess dilution of secretions for immunological and microbiological assays. J Clin Microbiol (1993) 1.11
Bacterial antibody assays in the diagnosis of acute lower respiratory tract infection in children. Pediatr Infect Dis J (1995) 1.10
Streptococcus pneumoniae in nasopharyngeal secretions of healthy children: comparison of real-time PCR and culture from STGG-transport medium. Mol Cell Probes (2004) 1.10
Chlamydia pneumoniae multiplies in human endothelial cells in vitro. Microb Pathog (1994) 1.10
Experimental infection of Chlamydia pneumoniae in mice. Microb Pathog (1993) 1.08